| Not Yet Recruiting | variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway NCT07463976 | The Royal Wolverhampton Hospitals NHS Trust | — |
| Not Yet Recruiting | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Y NCT07440290 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 NCT05770544 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial NCT06510699 | The University of Queensland | Phase 2 |
| Recruiting | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations NCT06988475 | Cancer Research UK | Phase 2 / Phase 3 |
| Not Yet Recruiting | Seen and Be Heard: Ensuring Fair Cancer Care for All Children NCT06481527 | Great Ormond Street Hospital for Children NHS Foundation Trust | — |
| Completed | Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Trans NCT06395220 | Peking University People's Hospital | — |
| Recruiting | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Pos NCT05770037 | Cancer Research UK | Phase 2 / Phase 3 |
| Active Not Recruiting | Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patie NCT06787326 | Hospital Universitari de Bellvitge | — |
| Recruiting | Safety and Feasibility of a Multidisciplinary Programme of Integrated Hospital-home Management With Early Disc NCT06814405 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Recruiting | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/ NCT05786716 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Posi NCT05768178 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indicat NCT05722886 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extensio NCT05678621 | Monash University | Phase 2 / Phase 3 |
| Unknown | Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation NCT05460013 | RenJi Hospital | N/A |
| Recruiting | Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for H NCT05379738 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Req NCT05298930 | Centre Leon Berard | N/A |
| Recruiting | The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs NCT05159245 | Helsinki University Central Hospital | Phase 2 |
| Unknown | Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignanc NCT05203809 | Malaghan Institute of Medical Research | — |
| Recruiting | oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort NCT05170347 | The University of Hong Kong | — |
| Unknown | Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies NCT04673305 | Ospedale San Carlo Borromeo | N/A |
| Unknown | Remote Monitoring of Cancer Patients With Suspected Covid-19 NCT04397705 | The Christie NHS Foundation Trust | Phase 1 |
| Completed | Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. NCT05352789 | Nottingham University Hospitals NHS Trust | — |
| Recruiting | Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment NCT05695638 | Morten Ladekarl | — |
| Unknown | Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies NCT04298892 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | — |
| Terminated | Nutrition Health Literacy of Cancer Patients and Their Support Networks. NCT03978312 | Nottingham University Hospitals NHS Trust | — |
| Recruiting | Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies NCT04068597 | CellCentric Ltd. | Phase 1 / Phase 2 |
| Completed | Rehabilitation Needs of the Malaysian Haematological Cancer Survivors NCT04236063 | University of Malaya | — |
| Completed | Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematolog NCT04174053 | Centre Henri Becquerel | N/A |
| Completed | Central Venous Access Device Removal in Cancer Patients NCT03855969 | General Hospital Groeninge | — |
| Withdrawn | Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematolo NCT03688789 | Rennes University Hospital | N/A |
| Withdrawn | A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoieti NCT04331483 | Centre Leon Berard | N/A |
| Unknown | Economic Evaluation of Innovative Molecular Analyses in Onco-haematology NCT03750994 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient NCT03806764 | Melbourne Health | N/A |
| Unknown | Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation NCT03146468 | Melbourne Health | Phase 2 |
| Unknown | Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI NCT03262220 | Thomas Zilli | N/A |